Advancements in Cellular Therapies
- CAR T-cell therapy effectiveness in hematologic cancers.
- Novel immunotherapeutic agents targeting malignancies.
- Challenges in manufacturing personalized cell therapies.
International Conference on Hematologic Malignancies and Cellular Immunotherapy — ICHMCI 2027
Dates
9–10 March 2027
Venue
Macau, Macau
Field
Hematologic Malignancies and Cellular Immunotherapy
Original papers are invited in Hematologic Malignancies and Cellular Immunotherapy. Submit by 5 February 2027.
Topics include, but are not limited to:
Conference opens in
Step 1
Step 2
Step 3
Get the official templates and forms for ICHMCI 2027. Use the latest versions when preparing your submission.
Present your research, meet peers from over 50 countries and help shape the future of Hematologic Malignancies and Cellular Immunotherapy.